Interaction/NN
between/IN
Smoking/JJ
and/CC
the/DT
STAB2/NN
Gene/NN
in/IN
the/DT
Severity/NN
of/IN
Rheumatoid/JJ
Arthritis/NN
./.
====================
Rheumatoid/JJ
arthritis/NN
(/(
RA/NN
)/)
is/VBZ
a/DT
chronic/JJ
autoimmune/JJ
disorder/NN
that/DT
is/VBZ
characterized/VBN
by/IN
inflammation/NN
of/IN
the/DT
synovial/JJ
tissue/NN
and/CC
deterioration/NN
of/IN
the/DT
joint/NN
and/CC
bone/NN
./.
====================
A/DT
recent/JJ
study/NN
reported/VBD
a/DT
potential/JJ
gene-environment/JJ
interaction/NN
between/IN
HLA-DR/NN
and/CC
smoking/NN
./.
====================
The/DT
present/JJ
study/NN
investigated/VBD
whether/IN
a/DT
specific/JJ
gene/NN
was/VBD
related/JJ
to/TO
the/DT
association/NN
between/IN
smoking/NN
and/CC
the/DT
severity/NN
of/IN
RA/NN
(/(
rheumatoid/JJ
factor/NN
levels/NNS
＞20/CD
IU/ml/NN
)/)
./.
====================
We/PRP
used/VBD
the/DT
resources/NNS
of/IN
the/DT
NARAC/NN
family/NN
collection/NN
of/IN
GAW/NN
15/CD
databases/NNS
,/,
and/CC
1139/CD
subjects/NNS
with/IN
RF＞20/NN
IU/ml/NN
were/VBD
included/VBN
in/IN
the/DT
current/JJ
analysis/NN
./.
====================
The/DT
linkage/NN
panel/NN
contained/VBD
5858/CD
SNP/NN
markers/NNS
,/,
and/CC
5744/CD
SNPs/NNS
passed/VBN
quality/NN
control/NN
criteria/NNS
./.
====================
Linear/JJ
regression/NN
analyses/NNS
,/,
using/VBG
PLINK/NN
software/RB
and/CC
generalized/VBN
estimating/VBG
equation/NN
regression/NN
models/NNS
,/,
were/VBD
used/VBN
to/TO
test/VB
for/IN
associations/NNS
between/IN
the/DT
SNPs/NNS
and/CC
the/DT
severity/NN
of/IN
RA/NN
according/VBG
to/TO
smoking/NN
groups/NNS
./.
====================
Two/CD
major/JJ
findings/NNS
were/VBD
established/VBN
./.
====================
First/RB
,/,
the/DT
severity/NN
of/IN
RA/NN
in/IN
smokers/NNS
was/VBD
associated/VBN
with/IN
rs703618/NN
(/(
p=6×10−5/NN
)/)
,/,
which/WDT
lies/VBZ
in/IN
the/DT
intronic/JJ
region/NN
of/IN
the/DT
stabilin/NN
2/CD
(/(
STAB2/NN
)/)
gene/NN
on/IN
chromosome/NN
12/CD
./.
====================
Second/RB
,/,
there/EX
were/VBD
significant/JJ
differences/NNS
in/IN
the/DT
levels/NNS
of/IN
RF/NN
between/IN
‘/CD
ever/RB
smokers/NNS
’/CD
and/CC
‘/NN
never/RB
smokers/NNS
’/CD
according/VBG
to/TO
the/DT
rs703618/NN
genotype/NN
(/(
G/G/NN
,/,
A/G/NN
,/,
A/A/NN
)/)
./.
====================
We/PRP
investigated/VBD
whether/IN
a/DT
specific/JJ
gene/NN
acts/VBZ
as/IN
a/DT
mediator/NN
between/IN
smoking/NN
and/CC
the/DT
severity/NN
of/IN
RA/NN
and/CC
found/VBD
that/IN
the/DT
STAB2/NN
gene/NN
could/MD
affect/VB
this/DT
relationship/NN
./.
====================
Our/PRP$
finding/NN
indicates/VBZ
that/IN
smoking/NN
may/MD
mediate/VB
RA/NN
severity/NN
by/IN
affecting/VBG
the/DT
expression/NN
level/NN
of/IN
a/DT
specific/JJ
gene/NN
./.
====================
Rheumatoid/JJ
arthritis/NN
(/(
RA/NN
)/)
,/,
which/WDT
is/VBZ
a/DT
chronic/JJ
autoimmune/JJ
disorder/NN
that/DT
is/VBZ
characterized/VBN
by/IN
inflammation/NN
of/IN
the/DT
synovial/JJ
tissue/NN
and/CC
deterioration/NN
of/IN
the/DT
joint/NN
and/CC
bone/NN
,/,
causes/VBZ
severe/JJ
disability/NN
and/CC
increases/VBZ
mortality/NN
(/(
Lee/NNP
and/CC
Weinblatt/NN
,/,
2001/CD
)/)
./.
====================
There/EX
is/VBZ
substantial/JJ
evidence/NN
that/IN
genetic/JJ
factors/NNS
play/VBP
crucial/JJ
roles/NNS
in/IN
the/DT
occurrence/NN
of/IN
RA/NN
./.
====================
The/DT
genes/NNS
for/IN
MHC/NN
class/NN
II/CD
,/,
particularly/RB
the/DT
HLAlinked/JJ
genes/NNS
,/,
show/VBP
consistent/JJ
and/CC
strong/JJ
associations/NNS
with/IN
the/DT
onset/NN
of/IN
RA/NN
(/(
Gregersen/NNP
et/FW
al./FW
,/,
1987/CD
;/:
de/FW
Vries/NNS
et/FW
al./FW
,/,
2002/CD
;/:
Turesson/NN
and/CC
Matteson/NN
,/,
2006/CD
)/)
./.
====================
In/IN
addition/NN
,/,
several/JJ
environmental/JJ
factors/NNS
are/VBP
implicated/VBN
in/IN
the/DT
development/NN
or/CC
progression/NN
of/IN
RA/NN
(/(
Klareskog/NN
et/FW
al./FW
,/,
2006/CD
)/)
./.
====================
Of/IN
these/DT
factors/NNS
,/,
smoking/NN
is/VBZ
suspected/VBN
to/TO
be/VB
an/DT
important/JJ
contributor/NN
to/TO
the/DT
occurrence/NN
and/CC
severity/NN
of/IN
RA/NN
(/(
Harrison/NN
,/,
2002/CD
;/:
Alamanos/NN
and/CC
Drosos/NN
,/,
2005/CD
)/)
./.
====================
Silman/JJ
et/FW
al/JJ
./.
====================
(/(
1996/CD
)/)
investigated/VBD
smokingdiscordant/JJ
twin/NN
pairs/NNS
with/IN
RA/NN
and/CC
found/VBD
that/IN
smoking/NN
was/VBD
associated/VBN
with/IN
susceptibility/NN
to/TO
RA/NN
./.
====================
Smokers/NNS
show/VBP
an/DT
increased/VBN
incidence/NN
of/IN
RA/NN
and/CC
elevated/JJ
levels/NNS
of/IN
rheumatoid/JJ
factor/NN
(/(
RF/NN
)/)
(/(
Saag/NN
et/FW
al./FW
,/,
1997/CD
;/:
Masdottir/NNP
et/FW
al./FW
,/,
2000/CD
;/:
Wolfe/NNP
,/,
2000/CD
)/)
,/,
which/WDT
is/VBZ
an/DT
indicator/NN
of/IN
RA/NN
severity/NN
(/(
Cabral/JJ
et/FW
al./FW
,/,
2005/CD
)/)
./.
====================
Considering/VBG
that/DT
the/DT
occurrence/NN
of/IN
RA/NN
reflects/VBZ
the/DT
interaction/NN
between/IN
genetic/JJ
and/CC
environmental/JJ
factors/NNS
,/,
an/DT
approach/NN
to/TO
estimating/VBG
such/JJ
interactions/NNS
would/MD
be/VB
useful/JJ
in/IN
the/DT
detection/NN
of/IN
RA/NN
susceptibility/NN
genes/NNS
./.
====================
A/DT
recent/JJ
study/NN
reported/VBD
a/DT
potential/JJ
geneenvironment/JJ
interaction/NN
between/IN
the/DT
shared/JJ
epitope/NN
of/IN
HLADR/NN
and/CC
smoking/NN
./.
====================
In/IN
RFseropositive/JJ
RA/NN
,/,
HLADRB1/NN
genotypes/NNS
are/VBP
associated/VBN
with/IN
smoking/NN
,/,
which/WDT
means/NNS
that/DT
a/DT
gene/NN
that/WDT
is/VBZ
defined/VBN
as/IN
a/DT
risk/NN
factor/NN
for/IN
RA/NN
is/VBZ
strongly/RB
affected/VBN
by/IN
this/DT
environmental/JJ
factor/NN
(/(
Padyukov/NN
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
We/PRP
hypothesized/VBD
that/IN
smoking/NN
has/VBZ
a/DT
significant/JJ
effect/NN
on/IN
the/DT
elevation/NN
of/IN
RA/NN
and/CC
that/IN
this/DT
relationship/NN
is/VBZ
mediated/VBN
by/IN
the/DT
function/NN
of/IN
a/DT
specific/JJ
gene/NN
./.
====================
This/DT
purpose/NN
of/IN
this/DT
study/NN
was/VBD
to/TO
investigate/VB
the/DT
geneenvironment/JJ
interaction/NN
between/IN
smoking/NN
and/CC
the/DT
severity/NN
of/IN
RA/NN
./.
====================
We/PRP
used/VBD
the/DT
resources/NNS
of/IN
the/DT
15th/NN
Genetic/JJ
Analysis/NN
Workshop/NNP
(/(
GAW/NN
15/CD
)/)
database/NN
and/CC
the/DT
North/NN
American/NN
Rheumatoid/JJ
Arthritis/NN
Consortium/NN
(/(
NARAC/NN
)/)
family/NN
collec/JJ
tion/NN
./.
====================
Families/NNS
were/VBD
recruited/VBN
from/IN
12/CD
NARAC/NN
centers/NNS
in/IN
the/DT
USA/NN
according/VBG
to/TO
following/VBG
criteria/NNS
:/:
1/CD
)/)
at/IN
least/JJS
1/CD
sibling/NN
had/VBD
documented/VBN
erosions/NNS
on/IN
hand/NN
radiographs/NNS
;/:
and/CC
2/CD
)/)
at/IN
least/JJS
1/CD
sibling/NN
had/VBD
disease/NN
onset/NN
between/IN
the/DT
ages/NNS
of/IN
18/CD
and/CC
60/CD
years/NNS
(/(
Jawaheer/NNP
et/FW
al./FW
,/,
2001/CD
)/)
./.
====================
The/DT
dataset/NN
included/VBD
823/CD
families/NNS
(/(
92/CD
%/NN
Caucasian/JJ
,/,
5/CD
%/NN
Hispanic/JJ
,/,
2/CD
%/NN
African/JJ
,/,
0.6/CD
%/NN
Asian/JJ
,/,
and/CC
0.4/CD
%/NN
Native/JJ
American/NN
)/)
with/IN
1966/CD
affected/VBN
siblings/NNS
with/IN
RA/NN
./.
====================
Age/NN
,/,
sex/NN
,/,
smoking/NN
history/JJ
,/,
and/CC
serum/NN
RF/NN
were/VBD
evaluated/VBN
in/IN
the/DT
present/JJ
study/NN
./.
====================
Smoking/JJ
histories/NNS
were/VBD
categorized/VBN
as/IN
‘/RB
Ever/RB
smokers/NNS
’/CD
or/CC
‘/JJ
Never/RB
smokers/NNS
’/CD
after/IN
RA/NN
onset/NN
,/,
because/IN
RA/NN
patients/NNS
are/VBP
more/RBR
likely/JJ
to/TO
try/NN
to/TO
quit/RB
smoking/NN
,/,
and/CC
classifying/VBG
smokers/NNS
based/VBN
only/RB
on/IN
current/JJ
smoking/NN
status/NN
may/MD
underestimate/VB
the/DT
effect/NN
of/IN
smoking/VBG
./.
====================
Serum/NN
samples/NNS
were/VBD
collected/VBN
at/IN
study/NN
entry/NN
,/,
and/CC
RF/NN
IgM/NN
was/VBD
measured/VBN
using/VBG
a/DT
latex-enhanced/JJ
nephelometric/JJ
procedure/NN
./.
====================
RF/NN
production/NN
has/VBZ
been/VBN
considered/VBN
the/DT
leading/VBG
indicator/NN
of/IN
RA/NN
severity/NN
(/(
Cabral/JJ
et/FW
al./FW
,/,
2005/CD
)/)
,/,
although/IN
there/EX
is/VBZ
controversy/NN
due/JJ
to/TO
the/DT
detection/NN
of/IN
healthy/JJ
population/NN
and/CC
the/DT
relation/NN
with/IN
age/NN
(/(
Westwood/NN
et/FW
al./FW
,/,
2006/CD
)/)
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
defined/VBD
the/DT
severity/NN
of/IN
RA/NN
as/IN
more/RBR
than/IN
20/CD
IU/ml/NN
for/IN
RF/NN
levels/NNS
(/(
Aigner/NN
et/FW
al./FW
,/,
2007/CD
)/)
./.
====================
Finally/RB
,/,
the/DT
current/JJ
analysis/NN
included/VBD
1139/CD
subjects/NNS
(/(
689/CD
families/NNS
)/)
with/IN
RF＞20/NN
IU/ml/NN
./.
====================
Illumina/NN
performed/VBN
an/DT
analysis/NN
of/IN
genomewide/NN
SNPs/NNS
with/IN
commercially/RB
available/JJ
SNP/NN
panels/NNS
of/IN
all/DT
of/IN
the/DT
families/NNS
./.
====================
Samples/NNS
were/VBD
genotyped/VBN
using/VBG
the/DT
panel/NN
of/IN
5858/CD
SNPs/NNS
across/IN
the/DT
genome/NN
,/,
spaced/VBN
at/IN
an/DT
average/NN
distance/NN
of/IN
0.64/CD
cM/NN
(/(
Illumina/NN
Inc./NNP
,/,
San/NNP
Diego/JJ
CA/NN
,/,
USA/NNP
,/,
BeadArray/NNP
platform/NN
and/CC
GoldenGate/NN
assay/NN
)/)
./.
====================
Nearly/RB
all/DT
of/IN
these/DT
markers/NNS
(/(
98.1/CD
%/NN
)/)
passed/VBD
quality/NN
control/NN
filters/NNS
(/(
MAF＞5/NN
%/NN
,/,
SNP/NN
call/JJ
rate＞90/NN
%/NN
,/,
and/CC
HWE/NN
p/NN
value＞0.01/NN
)/)
,/,
giving/VBG
a/DT
total/JJ
yield/NN
of/IN
5744/CD
SNPs/NNS
./.
====================
The/DT
results/NNS
of/IN
the/DT
analysis/NN
of/IN
the/DT
NARAC/NN
Caucasian/JJ
families/NNS
have/VBP
been/VBN
published/VBN
(/(
Amos/NN
et/FW
al./FW
,/,
2006/CD
;/:
Taylor/JJ
et/FW
al./FW
,/,
2007/CD
)/)
./.
====================
Detailed/JJ
information/NN
on/IN
the/DT
study/NN
subjects/NNS
is/VBZ
available/JJ
at/IN
the/DT
NARAC/NN
website/JJ
(/(
http/NN
:/:
//www/JJ
./.
====================
naracdata/NNS
./.
====================
org/NN
)/)
./.
====================
The/DT
RF/NN
values/NNS
were/VBD
logtransformed/VBN
to/TO
assure/VB
a/DT
normal/JJ
distribution/NN
,/,
and/CC
smoking/NN
habits/VBZ
were/VBD
categorized/VBN
into/IN
‘/NN
ever/RB
smoker/NN
’/CD
and/CC
‘/NN
never/RB
smoker/NN
’/CD
groups/NNS
./.
====================
The/DT
data/NNS
analysis/NN
included/VBD
5744/CD
genomewide/NN
SNPs/NNS
(/(
MAF＞5/NN
%/NN
,/,
SNP/NN
call/JJ
rate＞90/NN
%/NN
,/,
and/CC
HWE/NN
p/NN
value＞0.01/NN
)/)
and/CC
the/DT
smoking/NN
habits/VBZ
of/IN
subjects/NNS
with/IN
RF/NN
levels/NNS
＞20/CD
IU/NN
./.
====================
For/IN
the/DT
groups/NNS
that/IN
were/VBD
stratified/VBN
by/IN
smoking/VBG
habits/VBZ
,/,
familybased/VBD
tests/NNS
of/IN
association/NN
using/VBG
PLINK/NN
software/JJ
(/(
http/NN
:/:
//pngu/FW
./.
====================
mgh/IN
./.
====================
harvard/RB
./.
====================
edu/∼purcell/plink//RB
)/)
were/VBD
performed/VBN
with/IN
all/DT
of/IN
the/DT
available/JJ
SNPs/NNS
,/,
and/CC
generalized/VBN
estimating/VBG
equation/NN
(/(
GEE/NN
)/)
regression/NN
models/NNS
were/VBD
used/VBN
to/TO
test/VB
for/IN
associations/NNS
between/IN
the/DT
SNPs/NNS
and/CC
the/DT
severity/NN
of/IN
RA/NN
according/VBG
to/TO
smoking/NN
groups/NNS
./.
====================
In/IN
the/DT
model/NN
,/,
the/DT
RF/NN
level/NN
was/VBD
used/VBN
as/IN
a/DT
response/NN
variable/JJ
,/,
and/CC
SNPs/NNS
,/,
age/NN
,/,
and/CC
sex/NN
were/VBD
used/VBN
as/IN
explanatory/JJ
variables/NNS
./.
====================
To/TO
show/VB
interaction/NN
between/IN
a/DT
significant/JJ
SNP/NN
and/CC
smoking/NN
status/NN
,/,
we/PRP
calculated/VBD
the/DT
mean/JJ
RF/NN
values/NNS
for/IN
the/DT
3/CD
genotypes/NNS
(/(
G/G/NN
,/,
A/G/NN
,/,
A/A/NN
)/)
of/IN
a/DT
significant/JJ
SNP/NN
and/CC
presented/VBN
the/DT
least/JJS
square/RB
means/NNS
(/(
95/CD
%/NN
confidence/NN
intervals/NNS
)/)
for/IN
each/DT
allele/NN
after/IN
adjustment/JJ
for/IN
age/NN
and/CC
sex/NN
(/(
Fig/NN
./.
====================
4/CD
)/)
,/,
using/VBG
SAS/NN
software/JJ
package/NN
version/NN
./.
====================
9.1/CD
(/(
SAS/NN
institute/JJ
Inc./NNP
)/)
./.
====================
Table/JJ
1/CD
lists/NNS
the/DT
general/JJ
characteristics/NNS
of/IN
the/DT
subjects/NNS
./.
====================
The/DT
mean/JJ
age/NN
was/VBD
57/CD
years/NNS
in/IN
males/NNS
and/CC
55/CD
years/NNS
in/IN
females/NNS
./.
====================
Seventythree/CD
percent/NN
of/IN
males/NNS
responded/VBD
to/TO
having/VBG
a/DT
smoking/NN
history/JJ
,/,
while/IN
52/CD
%/NN
of/IN
females/NNS
had/VBD
a/DT
smoking/NN
history/JJ
./.
====================
The/DT
mean/JJ
RF/NN
value/NN
was/VBD
higher/JJR
in/IN
males/NNS
(/(
362.9/CD
IU/NN
)/)
than/IN
in/IN
females/NNS
(/(
340.6/CD
IU/NN
)/)
./.
====================
RF/NN
(/(
＞20/CD
IU/ml/NN
)/)
is/VBZ
logtransformed/VBN
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
The/DT
results/NNS
from/IN
the/DT
genomewide/NN
association/NN
analysis/NN
of/IN
RF/NN
are/VBP
presented/VBN
in/IN
Fig/NN
./.
====================
2/CD
,/,
and/CC
the/DT
top/NN
4/CD
SNPs/NNS
(/(
p＜10−3/NN
)/)
are/VBP
summaized/VBN
in/IN
Table/JJ
2/CD
./.
====================
The/DT
significant/JJ
SNP/NN
in/IN
the/DT
association/NN
between/IN
smoking/NN
and/CC
RF/NN
was/VBD
rs703618/CD
(/(
p=6×10−5/NN
)/)
./.
====================
Using/VBG
the/DT
SNP/NN
database/NN
at/IN
the/DT
PubMed/JJ
website/JJ
,/,
we/PRP
confirmed/VBD
the/DT
position/NN
and/CC
gene/NN
name/NN
of/IN
rs703618/NN
(/(
Table/JJ
2/CD
and/CC
Fig/NN
./.
====================
3/CD
)/)
./.
====================
The/DT
rs703618/NN
SNP/NN
comprises/VBZ
3/CD
genotypes/NNS
(/(
G/G/NN
,/,
A/G/NN
,/,
A/A/NN
)/)
,/,
and/CC
G/G/NN
exists/VBZ
as/IN
the/DT
minor/JJ
allele/NN
./.
====================
‘/CD
Ever/RB
smokers/NNS
’/CD
with/IN
the/DT
A/A/NN
genotype/NN
had/VBD
higher/JJR
RF/NN
levels/NNS
than/IN
those/DT
with/IN
the/DT
G/G/NN
genotype/NN
./.
====================
In/IN
contrast/NN
,/,
the/DT
‘/NN
never/RB
smokers/NNS
’/CD
showed/VBD
similar/JJ
RF/NN
levels/NNS
for/IN
all/DT
3/CD
genotypes/NNS
./.
====================
There/EX
were/VBD
significant/JJ
differences/NNS
in/IN
the/DT
RF/NN
levels/NNS
of/IN
individuals/NNS
with/IN
the/DT
A/A/NN
genotype/NN
between/IN
‘/CD
ever/RB
smokers/NNS
’/CD
and/CC
‘/NN
never/RB
smokers/VBZ
,/,
’/NNP
while/IN
the/DT
G/G/NN
genotype/NN
was/VBD
not/RB
associated/VBN
with/IN
smoking/NN
status/NN
(/(
Table/JJ
3/CD
)/)
./.
====================
This/DT
trend/NN
was/VBD
retained/VBN
after/IN
adjustment/JJ
for/IN
age/NN
and/CC
sex/NN
(/(
Fig/NN
./.
====================
4/CD
)/)
./.
====================
The/DT
aim/NN
of/IN
the/DT
present/JJ
study/NN
was/VBD
to/TO
investigate/VB
whether/IN
a/DT
specific/JJ
gene/NN
was/VBD
related/JJ
to/TO
the/DT
association/NN
between/IN
smoking/NN
and/CC
the/DT
severity/NN
of/IN
RA/NN
(/(
in/IN
patients/NNS
with/IN
RF/NN
levels/NNS
＞20/CD
IU/ml/NN
)/)
./.
====================
Two/CD
major/JJ
findings/NNS
were/VBD
established/VBN
./.
====================
First/RB
,/,
the/DT
severity/NN
of/IN
RA/NN
in/IN
smokers/NNS
was/VBD
associated/VBN
with/IN
rs703618/NN
(/(
p=6×10−5/NN
)/)
,/,
which/WDT
lies/VBZ
in/IN
the/DT
intronic/JJ
region/NN
of/IN
the/DT
stabilin/NN
2/CD
(/(
STAB2/NN
)/)
gene/NN
on/IN
chromosome/NN
12/CD
./.
====================
Second/RB
,/,
there/EX
were/VBD
significant/JJ
differences/NNS
in/IN
the/DT
levels/NNS
of/IN
RF/NN
between/IN
‘/CD
ever/RB
smokers/NNS
’/CD
and/CC
‘/NN
never/RB
smokers/NNS
’/CD
according/VBG
to/TO
the/DT
rs703618/NN
genotype/NN
(/(
G/G/NN
,/,
A/G/NN
,/,
A/A/NN
)/)
./.
====================
The/DT
RF/NN
levels/NNS
were/VBD
significantly/RB
increased/VBD
in/IN
‘/NN
ever/RB
smokers/NNS
’/CD
with/IN
the/DT
A/A/NN
genotype/NN
,/,
while/IN
the/DT
RF/NN
levels/NNS
in/IN
‘/NN
never/RB
smokers/NNS
’/CD
did/VBD
not/RB
differ/VB
between/IN
the/DT
genotypes/NNS
./.
====================
In/IN
fact/NN
,/,
this/DT
finding/NN
of/IN
the/DT
study/NN
,/,
in/IN
which/WDT
we/PRP
looked/VBD
at/IN
how/WRB
a/DT
specific/JJ
gene/NN
mediates/VBZ
the/DT
relationship/NN
between/IN
smoking/NN
and/CC
RA/NN
severity/NN
,/,
may/MD
be/VB
a/DT
false/JJ
positive/JJ
or/CC
a/DT
pattern/NN
of/IN
linkage/NN
disequilibrium/NN
due/JJ
to/TO
the/DT
multiple/JJ
comparison/NN
issue/NN
./.
====================
Also/RB
,/,
the/DT
statistical/JJ
significance/NN
of/IN
our/PRP$
result/NN
is/VBZ
not/RB
strong/JJ
./.
====================
However/RB
,/,
we/PRP
found/VBD
certain/JJ
evidence/NN
to/TO
support/VB
the/DT
association/NN
due/JJ
to/TO
the/DT
robust/JJ
methods/NNS
(/(
i./FW
e./FW
,/,
data/NNS
collection/NN
,/,
using/VBG
a/DT
powerful/JJ
statistical/JJ
tool/NN
)/)
and/CC
biological/JJ
plausibility/NN
./.
====================
The/DT
NARAC/NN
dataset/NN
that/DT
was/VBD
used/VBN
in/IN
the/DT
present/JJ
analysis/NN
is/VBZ
reliable/JJ
and/CC
stable/JJ
,/,
having/VBG
been/VBN
generated/VBN
at/IN
12/CD
centers/NNS
in/IN
the/DT
USA/NN
with/IN
well-defined/JJ
protocols/NNS
./.
====================
The/DT
data/NNS
were/VBD
collected/VBN
using/VBG
strict/JJ
and/CC
consistent/JJ
criteria/NNS
for/IN
inclusion/NN
and/CC
exclusion/NN
,/,
and/CC
hand/NN
radiographs/NNS
were/VBD
used/VBN
as/IN
an/DT
entry/NN
criterion/NN
in/IN
the/DT
NARAC/NN
study/NN
to/TO
ensure/VB
reliability/NN
in/IN
the/DT
diagnosis/NN
of/IN
RA/NN
and/CC
to/TO
avoid/VB
disease/NN
misclassification/NN
(/(
Jawaheer/NN
et/FW
al./FW
,/,
2001/CD
)/)
./.
====================
Here/RB
,/,
our/PRP$
results/NNS
were/VBD
obtained/VBN
from/IN
the/DT
PLINK/NN
software/RB
package/NN
,/,
which/WDT
is/VBZ
a/DT
powerful/JJ
statistical/JJ
tool/NN
for/IN
association/NN
analyses/NNS
of/IN
individual/JJ
and/CC
family-based/VBD
data/NNS
(/(
Purcell/NN
et/FW
al./FW
,/,
2007/CD
)/)
./.
====================
Furthermore/RB
,/,
the/DT
rs703618/NN
SNP/NN
(/(
STAB2/NN
gene/NN
)/)
that/WDT
was/VBD
observed/VBN
in/IN
the/DT
present/JJ
study/NN
has/VBZ
a/DT
biological/JJ
role/NN
that/WDT
is/VBZ
related/JJ
to/TO
immune/JJ
function/NN
./.
====================
The/DT
STAB2/NN
gene/NN
encodes/VBZ
the/DT
hyaluronan/NN
receptor/NN
for/IN
endocytosis/NN
(/(
HARE/NN
)/)
,/,
which/WDT
mediates/VBZ
hyaluronan/NN
and/CC
chondroitin/NN
sulfate/NN
clearance/NN
from/IN
the/DT
lymph/NN
and/CC
blood/NN
(/(
Harris/NN
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
Hyaluronan/NN
,/,
which/WDT
is/VBZ
an/DT
important/JJ
component/NN
of/IN
synovial/JJ
fluid/NN
and/CC
extracellular/JJ
matrix/NN
,/,
is/VBZ
a/DT
glycosaminoglycan/NN
polymer/NN
of/IN
repeated/JJ
units/NNS
of/IN
Nacetylglucosamine/NN
and/CC
glucuronic/JJ
acid/NN
./.
====================
Hyaluronan/NN
plays/VBZ
essential/JJ
roles/NNS
in/IN
embryogenesis/NN
,/,
angiogenesis/NN
,/,
cell/NN
proliferation/NN
,/,
and/CC
wound/NN
healing/NN
(/(
Stern/NN
et/FW
al./FW
,/,
2006/CD
;/:
Kogan/NN
et/FW
al./FW
,/,
2007/CD
)/)
./.
====================
It/PRP
has/VBZ
been/VBN
reported/VBN
that/IN
hyaluronan/NN
modulates/VBZ
antiinflammatory/JJ
and/CC
immunosuppressive/JJ
functions/NNS
(/(
Delmage/NN
et/FW
al./FW
,/,
1986/CD
;/:
Bollyky/NNP
et/FW
al./FW
,/,
2007/CD
)/)
./.
====================
Bollyky/RB
et/FW
al/JJ
./.
====================
(/(
2007/CD
)/)
have/VBP
suggested/VBN
that/IN
highmolecularweight/VBP
hyaluronan/NN
enhances/VBZ
the/DT
suppressive/JJ
effects/NNS
of/IN
CD4＋CD25＋/JJ
regulatory/JJ
T/NN
cells/NNS
,/,
and/CC
this/DT
may/MD
provide/VB
a/DT
clue/NN
as/IN
to/TO
the/DT
cellular/JJ
immune/JJ
response/NN
./.
====================
RA/NN
patients/NNS
show/VBP
elevated/JJ
HA/NN
levels/NNS
in/IN
their/PRP$
sera/NNS
and/CC
synovial/JJ
fluid/NN
(/(
EngströmLaurent/NN
et/FW
al./FW
,/,
1985/CD
;/:
Goldberg/NNP
et/FW
al./FW
,/,
1991/CD
;/:
Nagaya/NNP
et/FW
al./FW
,/,
1999/CD
;/:
Majeed/JJ
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
Although/IN
the/DT
role/NN
of/IN
the/DT
STAB2/NN
gene/NN
in/IN
the/DT
relationship/NN
between/IN
smoking/NN
and/CC
RA/NN
severity/NN
remains/VBZ
questionable/JJ
,/,
smoking/VBG
appears/VBZ
to/TO
be/VB
related/JJ
to/TO
RA/NN
severity/NN
(/(
or/CC
increased/VBD
RF/NN
levels/NNS
)/)
in/IN
terms/NNS
of/IN
the/DT
impairment/JJ
and/CC
abnormality/NN
of/IN
immune/JJ
functions/NNS
(/(
HarelMeir/NNP
et/FW
al./FW
,/,
2007/CD
)/)
;/:
during/IN
these/DT
processes/NNS
,/,
the/DT
STAB2/NN
gene/NN
appears/VBZ
to/TO
reinforce/VB
the/DT
alteration/NN
of/IN
immune/JJ
responses/NNS
./.
====================
Thus/RB
,/,
stimulation/NN
of/IN
the/DT
STAB2/NN
gene/NN
due/JJ
to/TO
smoking/NN
may/MD
influence/VB
immune/JJ
function/NN
and/CC
contribute/VBP
to/TO
the/DT
severity/NN
of/IN
RA/NN
./.
====================
Our/PRP$
study/NN
has/VBZ
some/DT
major/JJ
limitations/NNS
./.
====================
This/DT
study/NN
was/VBD
a/DT
caseonly/RB
design/NN
./.
====================
This/DT
is/VBZ
a/DT
good/JJ
approach/NN
to/TO
screen/VB
geneenvironment/JJ
interactions/NNS
with/IN
small/JJ
standard/JJ
errors/NNS
,/,
but/CC
it/PRP
is/VBZ
difficult/JJ
to/TO
generalize/VB
results/NNS
for/IN
the/DT
general/JJ
population/NN
due/JJ
to/TO
the/DT
case/NN
selection/NN
,/,
and/CC
its/PRP$
results/NNS
may/MD
be/VB
caused/VBN
by/IN
the/DT
linkage/NN
disequilibrium/NN
between/IN
markers/NNS
and/CC
alleles/NNS
(/(
Ahn/NN
et/FW
al./FW
,/,
2005/CD
;/:
Ahn/NNP
,/,
2006/CD
)/)
./.
====================
We/PRP
also/RB
restricted/JJ
the/DT
analysis/NN
to/TO
a/DT
comparison/NN
of/IN
‘/NN
ever/RB
smokers/NNS
’/CD
and/CC
‘/NN
never/RB
smokers/NNS
’/CD
and/CC
did/VBD
not/RB
consider/VB
the/DT
number/NN
of/IN
packs/NNS
of/IN
cigarettes/NNS
that/DT
were/VBD
smoked/VBN
daily/RB
./.
====================
Some/DT
studies/NNS
have/VBP
reported/VBN
that/IN
smoking/NN
is/VBZ
associated/VBN
with/IN
both/DT
the/DT
duration/NN
and/CC
number/NN
of/IN
packs/NNS
that/DT
is/VBZ
smoked/VBN
by/IN
RA/NN
patients/NNS
(/(
Stolt/NN
et/FW
al./FW
,/,
2003/CD
;/:
Costenbader/NN
et/FW
al./FW
,/,
2006/CD
)/)
./.
====================
However/RB
,/,
because/IN
RA/NN
patients/NNS
are/VBP
more/RBR
likely/RB
to/TO
try/NN
to/TO
quit/RB
smoking/NN
,/,
and/CC
because/IN
we/PRP
considered/VBD
that/IN
smoking/VBG
would/MD
have/VBP
a/DT
triggering/VBG
effect/NN
on/IN
RA/NN
(/(
Klareskog/NN
et/FW
al./FW
,/,
2007/CD
)/)
,/,
the/DT
classification/NN
of/IN
‘/JJ
ever/RB
smokers/VBZ
’/CD
and/CC
‘/FW
never/RB
smokers/VBZ
’/CD
is/VBZ
not/RB
likely/JJ
to/TO
involve/VB
a/DT
substantial/JJ
bias/NNS
./.
====================
As/IN
mentioned/VBN
above/JJ
,/,
the/DT
issues/NNS
about/RB
statistical/JJ
power/JJR
and/CC
multiple/JJ
comparisons/NNS
appear/VBP
to/TO
be/VB
insufficiently/RB
strong/JJ
enough/IN
to/TO
confirm/VB
our/PRP$
findings/NNS
./.
====================
This/DT
caveat/NN
must/MD
be/VB
considered/VBN
when/WRB
interpreting/VBG
these/DT
findings/NNS
./.
====================
In/IN
conclusion/NN
,/,
we/PRP
investigated/VBD
whether/IN
a/DT
specific/JJ
gene/NN
acts/VBZ
as/IN
a/DT
mediator/NN
between/IN
smoking/NN
and/CC
the/DT
severity/NN
of/IN
RA/NN
by/IN
indicating/VBG
the/DT
elevation/NN
of/IN
RA/NN
and/CC
found/VBD
that/IN
the/DT
STAB2/NN
gene/NN
could/MD
affect/VB
this/DT
relationship/NN
./.
====================
Our/PRP$
finding/NN
indicates/VBZ
that/IN
smoking/NN
mediates/VBZ
RA/NN
severity/NN
by/IN
affecting/VBG
the/DT
manifestation/NN
of/IN
a/DT
specific/JJ
gene/NN
and/CC
suggests/VBZ
the/DT
possibility/NN
of/IN
gene-environment/JJ
interactions/NNS
between/IN
smoking/NN
and/CC
RA/NN
severity/NN
./.
====================
Further/RB
studies/NNS
are/VBP
required/VBN
to/TO
elucidate/VB
the/DT
biological/JJ
significance/NN
of/IN
this/DT
finding/NN
./.
====================
Furthermore/RB
,/,
it/PRP
seems/VBZ
likely/JJ
that/IN
an/DT
understanding/NN
of/IN
the/DT
gene-environment/JJ
interactions/NNS
will/MD
be/VB
essential/JJ
for/IN
the/DT
detection/NN
of/IN
susceptibility/NN
genes/NNS
for/IN
complex/NN
diseases/NNS
./.
====================
